Skip To Content
Free consultation Text or call 312.553.4900

FDA To Review First Three New Weight Loss Drugs

July 20, 2010  ·  By HM&M


With the U.S. obesity rates approaching 35 percent of adults, many are excited to get “their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects.” (Matthew Perrone, Washington AP, 7/12).

As a personal injury and products liability attorney in Chicago, I am always skeptical of new drugs, and weight loss drugs in general, especially since “two of the drugs submitted for approval simply combine existing drugs – an anticonvulsant and an amphetamine – but have worrying side effects. The third, a new medication, is safer but less effective.” Results of the FDA review are due shortly.

The obesity endemic in this country is certainly troubling, but, as always, proper and thorough testing of impending drugs is necessary.

July 20, 2010

V.A. Is Easing Rules To Cover Stress Disorder

In recent years, the number of cars recalled has increased. The recalls range from small issues, such as a mislabeled sticker or when a durability test found that a spring wears out prematurely, to large recalls, like Takata airbags that can possibly explode and spray shrapnel in the driver's or passenger's face, causing serious injury... Read More

July 20, 2010

Parents Turn Efforts To Pool Safety

Earlier this week, fifteen people aboard a “party bus” were injured when their vehicle was sideswiped by a SUV on the Eisenhower Expressway in Chicago. Although most of the injuries were minor, one person suffered a broken leg. The driver of the SUV was later charged with a DUI. The driver of the party bus... Read More

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.